You Make the Call

You Make the Call

Each month we’ll pick a challenging clinical question submitted through the Consult-a-Colleague program and post the expert’s response.

The significance of JAK2-positive test results in a healthy patient

This month Josef Prchal, MD, discusses the significance of JAK2-positive test results in a healthy patient. And don't forget to check out next month's clinical dilemma...

Best options for an older patient with Ph+ B-cell ALL

This month, Wendy Stock, MD, discusses best options for an older patient with Philadelphia chromosome (Ph)–positive B-cell acute lymphocytic leukemia (ALL). And don't forget to...

Treatment options for a young woman with stage 2a Hodgkin lymphoma and fertility concerns

This month, David Straus, MD, discusses treatment options for a young woman with stage 2a Hodgkin lymphoma and fertility concerns. And don't forget to check...

How to Treat HELLP Syndrome

This month Saskia Middeldorp, MD, discusses treatment of HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome. And don't forget to check out next month's clinical...

How to Treat Ph-Negative Precursor B-Cell ALL and Ischemic Cardiomyopathy

This month, Anjali S. Advani, MD, discusses the management of Ph-negative ALL in a patient with ischemic cardiomyopathy. And don't forget to check out next...

How to Treat Anemia in a Patient Who Refuses Transfusions for Religious Reasons

This month, Neil A. Zakai, MD, discusses how to treat anemia in a patient who refuses packed red blood cells. And don't forget to check out...

From ASH Meeting on Hematologic Malignancies: Treating Patients With AML With Mutations and Minimal...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: Treating “Problematic” Cases of Polycythemia Vera

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

From ASH Meeting on Hematologic Malignancies: Treating a Young Patient With Newly Diagnosed ALL

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

How would you treat a patient with autoimmune hepatitis, grade 4 cirrhosis, and declining...

This month, Spero Cataland, MD, discusses whether a patient with thrombocytopenia has hypersplenism, immune thrombocytopenia, or both. And don't forget to check out next month's...
Advertisement

Current Issue

March 2019, Volume 5, Issue 4

This issue features a look at the misconceptions about travel-associated blood clots, the treatment of young patients with myeloma, and more.